Drugs / Autologous Human Platelet Lysate
Autologous Human Platelet Lysate
Trials 3
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT01644435 | May → Oct 2012 | acne | Kasiak Research Pvt. Ltd. | Completed | No outcome recorded |
| Phase 1/2 | NCT01668862 | Mar → Oct 2012 | epicondylitis | Kasiak Research Pvt. Ltd. | Unknown | No outcome recorded |
| Phase 1/2 | NCT01644422 | Jan → Oct 2012 | androgenetic alopecia | Kasiak Research Pvt. Ltd. | Unknown | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 3 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Autologous Human Platelet Lysate | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01644422 ↗ |
| Modality | Other / unclassified | “Biological: Autologous Human Platelet Lysate” NCT01644435 ↗ |
| Route | Other | “one injection of Autologous Human Platelet Lysate in the lateral epicondyle space” NCT01668862 ↗ |